Martin Pecherstorfer, MD

Professor
University Hospital Krems, Department of Internal Medicine 2, Karl Landsteiner Private University of Health Sciences, Austria

N/A

Poster(s):

• 1205 - Rituximab Maintenance after Chemoimmunotherapy Induction in 1st and 2nd Line Improves Progression Free Survival: Long Term Follow up of the International Randomized AGMT-CLL8/a Mabtenance Trial